Matrix metalloproteinases - biochemical characteristics and clinical value determination in breast cancer patiets

Journal Title: Współczesna Onkologia - Year 2005, Vol 9, Issue 8

Abstract

The matrix metalloproteinases (MMPs) constitute a group of zinc-dependent endopeptidases, which primary function is remodelling of components in the extracellular matrix. These enzymes are synthetized in cells, and secreted to the extracellular space as an inactive form (proMMP). Activation of the enzyme is followed by the cleavage in the propeptide region. The activity of metalloproteinases is strictly regulated at the transcriptional, translation levels and by endogenous inhibitors, including α2-macroglobulin and tissue inhibitors of metalloproteinases (TIMPs). Under physiological conditions matrix metalloproteinases are involved in processes i. e. embryogenesis, angiogenesis, wound healing and in platelet aggregation, regulation of ion metabolism. There is evidence that matrix metalloproteinases activity changes in many pathological conditions, including inflammatory, degenerative disorders and in cancer. Metalloproteinases play an important role in tumor progression by increasing cancer-cell growth, migration, invasion, metastasis and angiogenesis. The expression and activity of MMPs are increased in almost every type of human cancer, and this correlates with tumor stage, increased invasion and potential metastasis, and shortened survival. Among the different MMPs, especially MMP-2 (gelatinase A) and MMP-9 (gelainase B) play an important role in cancer invasion because of their ability to degrade type IV collagen, a major component of basement membranes.

Authors and Affiliations

Izabela Śliwowska, Zygmunt Kopczyński

Keywords

Related Articles

Extreme hyponatremia due to the syndrome of inappropriate antidiuretic hormone secretion (SIADH)in a patient with a small cell lung cancer - a case report and literature review

Introduction: A case of symptomatic SIADH syndrome with an extremely low sodium level occurring at the beginning of the treatment course in a patient with small cell lung cancer is described. Case report: A 64-year-old...

Metabolizm histaminy w tkance pierwotnych raków przewodowych gruczołu piersiowego

Celem pracy jest ocena zależności między stężeniami histaminy w osoczu i tkankach pierwotnych raków gruczołu piersiowego u kobiet oraz aktywność enzymów biorących udział w metabolizmie histaminy. Badaniem objęto 95 kobie...

Analysis of histopathological examination results concerning biopsy material taken during pancreas, liver and kidney cyst drainage

In years 1997–2003 the authors performed 555 subcutaneous drainages of pancreas, kidneys and liver cysts under USG control, each time taking a biopsy specimen for histopathological examination. Neoplastic disease was d...

High-dose chemotherapy supported with autologous hematopoietic stem cell transplant in small-cell lung cancer

Small-cell lung cancer provides clinicians with a paradox. Although it is a highly chemosensitive disease, it remains ultimately fatal for the majority of patients. The majority of patients respond to first-line chemothe...

Cancer pain in children and adolescents

As far as population of growth age is concerned, every year, in Poland there are 1100 to 1300 new cases of going down with cancer. The most common cases are leukemia, tumour, lymphoma (59.3% of all children’s cancer ca...

Download PDF file
  • EP ID EP91079
  • DOI -
  • Views 46
  • Downloads 0

How To Cite

Izabela Śliwowska, Zygmunt Kopczyński (2005). Matrix metalloproteinases - biochemical characteristics and clinical value determination in breast cancer patiets. Współczesna Onkologia, 9(8), 327-335. https://europub.co.uk/articles/-A-91079